The absence of evidence for major effects of the frequent SNP +299G > A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 61, Issue 3, 2003, Pages 191-198

  Ochi, Masaaki ^a   Osawa, Haruhiko ^a   Onuma, Hiroshi ^a   Murakami, Akiko ^a   Nishimiya, Tatsuya ^a   Shimada, Fumio ^b   Kato, Kenichi ^c   Shimizu, Ikki ^c   Shishino, Koji ^a   Murase, Mitsuharu ^a   Fujii, Yasuhisa ^c   Ohashi, Jun ^d   Makino, Hideichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

^c Ehime Prefectural Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Insulin resistance; Lysosomal acid lipase; Phosphodiesterase 3B; Resistin; Single nucleotide polymorphism; Type 2 diabetes; 3 Adrenergic receptor

Indexed keywords

ACID LIPASE; ARGININE; BETA 3 ADRENERGIC RECEPTOR; PHOSPHODIESTERASE; PHOSPHODIESTERASE 3B; PROLINE; RESISTIN; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; GENE; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LYSOSOME; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESISTIN GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 10744231305     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00119-0     Document Type: Article

References (28)

1. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:1992;318-368.
2. McCarthy M.I., Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 283:2002;E217-225.
3. McCarthy M.I., Hattersley A.T. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Exp. Rev. Mol. Diagn. 1:2001;403-412.
4. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature. 409:2001;307-312.
5. Osawa H., Onuma H., Murakami A., et al. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes. 51:2002;863-866.
6. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75:1995;473-486.
7. Bergman R.N. New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Rec. Prog. Horm. Res. 52:1997;359-385.
8. Lonnqvist F., Thome A., Nilsell K., Hoffstedt J., Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J. Clin. Invest. 95:1995;1109-1116.
9. Francis S.H., Turko I.V., Corbin J.D. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol. 65:2001;1-52.
10. Nagaoka T., Shirakawa T., Balon T.W., Russell J.C., Fujita-Yamaguchi Y. Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats. Diabetes. 47:1998;1135-1144.
11. Tang Y., Osawa H., Onuma H., Nishimiya T., Ochi M., Makino H. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes. 48:1999;1830-1835.
12. Tang Y., Osawa H., Onuma H., et al. Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse. Eur. J. Endocrinol. 145:2001;93-99.
13. Tang Y., Osawa H., Onuma H., et al. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse. Diabetes Res. Clin. Pract. 54:2001;145-155.
14. Anderson R.A., Sando G.N. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J. Biol. Chem. 266:1991;22479-22484.
15. Klima H., Ullrich K., Aslanidis C., Fehringer P., Lackner K.J., Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J. Clin. Invest. 92:1993;2713-2718.
16. Widen E., Lehto M., Kanninen T., Walston J., Shuldiner A.R., Groop L.C. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New Engl. J. Med. 333:1995;348-351.
17. Yoshioka K., Yoshida T., Sakane N., et al. Association of Trp64Arg mutation of the beta 3-adrenergic receptor gene with NIDDM, current and maximal body mass index. Diabetologia. 39:1996;1410-1411.
18. Fujisawa T., Ikegami H., Yamato E., et al. Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 39:1996;349-352.
19. Sano R., Miki T., Suzuki Y., et al. Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes. Diabetes Res. Clin. Pract. 54:2001;79-88.
20. Muntoni S., Wiebusch H., Funke H., et al. A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations. Hum. Genet. 97:1996;265-267.
21. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 23:(Suppl. 1):2000;S4-S19.
22. Osawa H., Onuma H., Murakami A., et al. Systematic search for single nucleotide polymorphisms in the insulin gene: evidence for a high frequency of -23T>A in Japanese subjects. Biochem. Biophys. Res. Commun. 286:2001;451-455.
23. Osawa H., Onuma H., Murakami A., et al. Systematic search for single nucleotide polymorphisms in the FOXC2 gene: the absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes. Diabetes. 52:2003;562-567.
24. Ma X., Warram J.H., Trischitta V., Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87:2002;4407-4410.
25. Wang H., Chu W.S., Hemphill C., Elbein S.C. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87:2002;2520-2524.
26. Sentinelli F., Romeo S., Arca M., et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes. 51:2002;860-862.
27. Engert J.C., Vohl M.-C., Williams S.M., et al. 5′ flanking variants of resistin are associated with obesity. Diabetes. 51:2002;1629-1634.
28. Pizzuti A., Argiolas A., Di Paola R., et al. An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J. Clin. Endocrinol. Metab. 87:2002;4403-4406.